- Home
- Publications
- Publication Search
- Publication Details
Title
Human Sirtuin Regulators: The “Success” Stories
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-21
DOI
10.3389/fphys.2021.752117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quercetin as a Precursor for the Synthesis of Novel Nanoscale Cu (II) Complex as a Catalyst for Alcohol Oxidation with High Antibacterial Activity
- (2021) Zahra Moodi et al. BIOINORGANIC CHEMISTRY AND APPLICATIONS
- A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Resveratrol (Polygonum cuspidatum), Luteolin, and Fisetin (Rhus succedanea)
- (2021) Kathleen S. Hodgin et al. International Journal of Environmental Research and Public Health
- Mitochondrial Sirtuins in Stem cells and Cancer
- (2021) Amit Jaiswal et al. FEBS Journal
- Resveratrol and metabolic health in COPD: A proof-of-concept randomized controlled trial
- (2020) Rosanne JHCG. Beijers et al. CLINICAL NUTRITION
- Effects of resveratrol or estradiol on post-exercise endothelial function in estrogen-deficient postmenopausal women
- (2020) Cemal Ozemek et al. JOURNAL OF APPLIED PHYSIOLOGY
- Quercetin protects against diabetic encephalopathy via SIRT1/NLRP3 pathway in db/db mice
- (2020) Tian Hu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A Review on Structure, Modifications and Structure-Activity Relation of Quercetin and Its Derivatives
- (2020) Rubin Thapa Magar et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Endometriosis
- (2020) Krina T. Zondervan et al. NEW ENGLAND JOURNAL OF MEDICINE
- No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial
- (2020) Marlies de Ligt et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Sirtuin activation targets IDH-mutant tumors
- (2020) Julie J Miller et al. NEURO-ONCOLOGY
- A randomized, double-blind, dose-ranging, pilot trial of piperine with resveratrol on the effects on serum levels of resveratrol
- (2020) Howard H. Bailey et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Resveratrol and exercise combined to treat functional limitations in late life: A pilot randomized controlled trial
- (2020) Sara A. Harper et al. EXPERIMENTAL GERONTOLOGY
- Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program
- (2020) G.C. Batista-Jorge et al. LIFE SCIENCES
- Quercetin alleviates kidney fibrosis by reducing renal tubular epithelial cell senescence through the SIRT1/PINK1/mitophagy axis
- (2020) Tao Liu et al. LIFE SCIENCES
- Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
- (2020) Sarah J. Tabrizi et al. Nature Reviews Neurology
- Effect of resveratrol and quercetin on the susceptibility of Escherichia coli to antibiotics
- (2020) Oleg N. Oktyabrsky et al. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
- Quercetin improve ischemia/reperfusion-induced cardiomyocyte apoptosis in vitro and in vivo study via SIRT1/PGC-1α signaling
- (2019) Jiayou Tang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Resveratrol and Its Human Metabolites—Effects on Metabolic Health and Obesity
- (2019) Margherita Springer et al. Nutrients
- Chemical screens in a zebrafish model of CHARGE syndrome identifies small molecules that ameliorate disease-like phenotypes in embryo
- (2019) Zainab Asad et al. European Journal of Medical Genetics
- Updates on the epigenetic roles of sirtuins
- (2019) Tatsiana Kosciuk et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- SIRT6, a Mammalian deacylase with multitasking abilities
- (2019) Andrew R Chang et al. PHYSIOLOGICAL REVIEWS
- P.58No effect of resveratrol supplementation in patients with mitochondrial myopathy - a randomized, double-blind, placebo-controlled, cross-over study
- (2019) N. Løkken et al. NEUROMUSCULAR DISORDERS
- Higher dose of resveratrol elevated cardiovascular disease risk biomarker levels in overweight older adults – A pilot study
- (2019) R.T. Mankowski et al. EXPERIMENTAL GERONTOLOGY
- Structural basis for the activation and inhibition of Sirtuin 6 by quercetin and its derivatives
- (2019) Weijie You et al. Scientific Reports
- Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation
- (2018) Simona Bo et al. ACTA DIABETOLOGICA
- Beneficial effects of acute trans-resveratrol supplementation in treated hypertensive patients with endothelial dysfunction
- (2018) B.C.A.A Marques et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology
- (2018) Surinder Kumar et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial
- (2018) Konstantinos Kantartzis et al. DIABETES OBESITY & METABOLISM
- No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease
- (2018) Marianne K. Poulsen et al. DIABETES OBESITY & METABOLISM
- Bacteriostatic Effect of Quercetin as an Antibiotic Alternative In Vivo and Its Antibacterial Mechanism In Vitro
- (2018) Shengan Wang et al. JOURNAL OF FOOD PROTECTION
- Supplementation with Resveratrol and Curcumin Does Not Affect the Inflammatory Response to a High-Fat Meal in Older Adults with Abdominal Obesity: A Randomized, Placebo-Controlled Crossover Trial
- (2018) Cécile Vors et al. JOURNAL OF NUTRITION
- Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
- (2018) Somayyeh Asghari et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults – A randomized controlled trial
- (2018) Sebastian Huhn et al. NEUROIMAGE
- Sirtuin activators and inhibitors: Promises, achievements, and challenges
- (2018) Han Dai et al. PHARMACOLOGY & THERAPEUTICS
- Antioxidant and anti-inflammatory activities of quercetin and its derivatives
- (2018) Marija Lesjak et al. Journal of Functional Foods
- Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes
- (2018) Marlies de Ligt et al. Molecular Metabolism
- Gene Expression of Sirtuin-1 and Endogenous Secretory Receptor for Advanced Glycation End Products in Healthy and Slightly Overweight Subjects after Caloric Restriction and Resveratrol Administration
- (2018) Alessandra Roggerio et al. Nutrients
- Natural polyphenols as sirtuin 6 modulators
- (2018) Minna Rahnasto-Rilla et al. Scientific Reports
- Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin
- (2018) Antonella Riva et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Solid Dispersion of Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Microparticles Improves Oral Bioavailability
- (2018) Roberto Spogli et al. Nutrients
- Activity of quercetin and kaemferol against Streptococcus mutans biofilm
- (2018) Yan Zeng et al. ARCHIVES OF ORAL BIOLOGY
- No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial
- (2017) Thomas Nordstrøm Kjær et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
- (2017) Charbel Moussa et al. Journal of Neuroinflammation
- Resveratrol Improves Vascular Function and Mitochondrial Number but Not Glucose Metabolism in Older Adults
- (2017) Rena M Pollack et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Synthesis of regioselectively acylated quercetin analogues with improved antiplatelet activity
- (2017) Yu Duan et al. Molecular Medicine Reports
- Research Progress in the Modification of Quercetin Leading to Anticancer Agents
- (2017) Alessandro Massi et al. MOLECULES
- KRAS Activation and over-expression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone Resistance
- (2017) Jung-Yoon Yoo et al. Scientific Reports
- Impact of Resveratrol on Glucose Control, Hippocampal Structure and Connectivity, and Memory Performance in Patients with Mild Cognitive Impairment
- (2017) Theresa Köbe et al. Frontiers in Neuroscience
- Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease
- (2017) Mary M. McDermott et al. JAMA Cardiology
- Antiviral activity of quercetin-3-β-O-D-glucoside against Zika virus infection
- (2017) Gary Wong et al. VIROLOGICA SINICA
- Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial
- (2016) Silvie Timmers et al. DIABETES CARE
- Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis
- (2016) Bruce E. Sands et al. INFLAMMATORY BOWEL DISEASES
- Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial
- (2016) Beata Banaszewska et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Resveratrol Supplementation in Nrf2 and NF-κB Expressions in Nondialyzed Chronic Kidney Disease Patients: A Randomized, Double-Blind, Placebo-Controlled, Crossover Clinical Trial
- (2016) Juliana F. Saldanha et al. JOURNAL OF RENAL NUTRITION
- Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
- (2016) Sara Heebøll et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation
- (2016) Xuben Hou et al. Scientific Reports
- Resveratrol Supplementation Did Not Improve Cognition in Patients with Schizophrenia: Results from a Randomized Clinical Trial
- (2016) Karine Zortea et al. Frontiers in Psychiatry
- Sirt1 activation by resveratrol is substrate sequence-selective
- (2016) Mahadevan Lakshminarasimhan et al. Aging-US
- Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition
- (2016) Dohyun Park et al. Scientific Reports
- Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets
- (2016) Ángela Rojas et al. Scientific Reports
- Resveratrol supplementation: Where are we now and where should we go?
- (2015) Marta G. Novelle et al. AGEING RESEARCH REVIEWS
- Safety, pharmacokinetics, pharmacogenomics and QT concentration−effect modelling of the SirT1 inhibitor selisistat in healthy volunteers
- (2015) Goran Westerberg et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
- (2015) Sigurd D. Süssmuth et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Selective Sirtuin 1 Activator SRT2104 Reduces Endotoxin-Induced Cytokine Release and Coagulation Activation in Humans*
- (2015) Anne J. van der Meer et al. CRITICAL CARE MEDICINE
- The combination of resveratrol and quercetin enhances the individual effects of these molecules on triacylglycerol metabolism in white adipose tissue
- (2015) Noemí Arias et al. EUROPEAN JOURNAL OF NUTRITION
- Quercetin: A flavonol with multifaceted therapeutic applications?
- (2015) Gabriele D'Andrea FITOTERAPIA
- Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol
- (2015) Duanfang Cao et al. GENES & DEVELOPMENT
- A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
- (2015) R. Scott Turner et al. NEUROLOGY
- Nutraceutical activators of AMPK/Sirt1 axis inhibit viral production and protect neurons from neurodegenerative events triggered during HSV-1 infection
- (2015) Luis Leyton et al. VIRUS RESEARCH
- Crystallographic structure of a small molecule SIRT1 activator-enzyme complex
- (2015) Han Dai et al. Nature Communications
- Huntington disease
- (2015) Gillian P. Bates et al. Nature Reviews Disease Primers
- Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial
- (2015) Sanne M. van der Made et al. PLoS One
- A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis
- (2015) James G. Krueger et al. PLoS One
- A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes
- (2014) Arun Baksi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation
- (2014) Emma L. Wightman et al. BRITISH JOURNAL OF NUTRITION
- Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study
- (2014) Stephen D. Anton et al. EXPERIMENTAL GERONTOLOGY
- A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease
- (2014) Marianne R. Smith et al. HUMAN MOLECULAR GENETICS
- Effects of Resveratrol in Patients with Type 2 Diabetes Mellitus on Skeletal Muscle SIRT1 Expression and Energy Expenditure
- (2014) Kian Peng Goh et al. INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM
- Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKα1/SIRT1
- (2014) Jing Dong et al. JOURNAL OF LIPID RESEARCH
- Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
- (2014) Miriam Méndez-del Villar et al. Metabolic Syndrome and Related Disorders
- Distinct Patterns of Sirtuin Expression During Progression of Alzheimer’s Disease
- (2014) Mirjam I. Lutz et al. NEUROMOLECULAR MEDICINE
- SIRT1 in Neurodevelopment and Brain Senescence
- (2014) A. Zara Herskovits et al. NEURON
- Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
- (2014) Forouzan Faghihzadeh et al. NUTRITION RESEARCH
- Resveratrol plus carboxymethyl-β-glucan may affect respiratory infections in children with allergic rhinitis
- (2014) M. Miraglia Del Giudice et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- SIRT1 and other sirtuins in metabolism
- (2014) Hung-Chun Chang et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Regulation of SIRT1 by Oxidative Stress-Responsive miRNAs and a Systematic Approach to Identify Its Role in the Endothelium
- (2013) Zhen Chen et al. ANTIOXIDANTS & REDOX SIGNALING
- High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men
- (2013) Satya Dash et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The sirtuin inhibitor cambinol impairs MAPK signaling, inhibits inflammatory and innate immune responses and protects from septic shock
- (2013) Jérôme Lugrin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Targeting Sirtuin-1 in Huntington’s Disease: Rationale and Current Status
- (2013) Wenzhen Duan CNS DRUGS
- Anti-Inflammatory and Antioxidant Effects of Resveratrol in Healthy Smokers A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial
- (2013) S. Bo et al. CURRENT MEDICINAL CHEMISTRY
- Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects
- (2013) F. K. Knop et al. DIABETIC MEDICINE
- Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins
- (2013) Jessica L. Feldman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural and Functional Analysis of Human SIRT1
- (2013) Andrew M. Davenport et al. JOURNAL OF MOLECULAR BIOLOGY
- Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men
- (2013) Lasse Gliemann et al. JOURNAL OF PHYSIOLOGY-LONDON
- SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine
- (2013) Hong Jiang et al. NATURE
- Site-Specific Anticancer Effects of Dietary Flavonoid Quercetin
- (2013) Katrin Sak NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism
- (2013) M. Gertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators
- (2013) B. P. Hubbard et al. SCIENCE
- Cardiovascular Effects of a Novel SIRT1 Activator, SRT2104, in Otherwise Healthy Cigarette Smokers
- (2013) Sowmya Venkatasubramanian et al. Journal of the American Heart Association
- Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man
- (2012) Ethan Hoffmann et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
- (2012) Rakesh Popat et al. BRITISH JOURNAL OF HAEMATOLOGY
- Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
- (2012) Sung-Jun Park et al. CELL
- Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance
- (2012) Jun Yoshino et al. Cell Metabolism
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
- (2012) Nathan L. Price et al. Cell Metabolism
- The Role of the Anti-Amyloidogenic Secretase ADAM10 in Shedding the APP-like Proteins
- (2012) Kristina Endres et al. Current Alzheimer Research
- High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
- (2012) M. M. Poulsen et al. DIABETES
- SIRT1-mediated deacetylation of MeCP2 contributes to BDNF expression
- (2012) Loredana Zocchi et al. Epigenetics
- SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
- (2012) Chu-Xia Deng International Journal of Biological Sciences
- Resveratrol for primary prevention of atherosclerosis: Clinical trial evidence for improved gene expression in vascular endothelium
- (2012) Beamon Agarwal et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Structural Basis for Sirtuin Activity and Inhibition
- (2012) Hua Yuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency
- (2012) D Herranz et al. ONCOGENE
- SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells
- (2012) Z Wang et al. ONCOGENE
- A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers
- (2012) Vincenzo Libri et al. PLoS One
- The phenomenon of resveratrol: redefining the virtues of promiscuity
- (2011) John M. Pezzuto Annals of the New York Academy of Sciences
- Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases--Safety, Pharmacokinetics, and Pharmacodynamics
- (2011) L. M. Howells et al. Cancer Prevention Research
- Advances in Characterization of Human Sirtuin Isoforms: Chemistries, Targets and Therapeutic Applications
- (2011) Y. Cen et al. CURRENT MEDICINAL CHEMISTRY
- Effect of food on the pharmacokinetic profile of trans-resveratrol
- (2011) M. Vaz-da-Silva et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Enhancing the bioavailability of resveratrol by combining it with piperine
- (2011) Jeremy J. Johnson et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease
- (2011) Yuncheng Wu et al. NEUROSIGNALS
- Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
- (2011) J. Du et al. SCIENCE
- Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation
- (2010) David O Kennedy et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Pleiotropic mechanisms facilitated by resveratrol and its metabolites
- (2010) Barbara Calamini et al. BIOCHEMICAL JOURNAL
- Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
- (2010) H.-H. S. Chow et al. Cancer Prevention Research
- Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
- (2010) V. A. Brown et al. CANCER RESEARCH
- Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
- (2010) K. R. Patel et al. CANCER RESEARCH
- Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects
- (2010) Charles la Porte et al. CLINICAL PHARMACOKINETICS
- Molecular aspects on the interaction of quercetin and its metal complexes with DNA
- (2010) Jafar Ezzati Nazhad Dolatabadi INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- SIRT1 Activation by Small Molecules
- (2010) Han Dai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
- (2010) Michelle Pacholec et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GSK/Sirtris compounds dogged by assay artifacts
- (2010) Charlie Schmidt NATURE BIOTECHNOLOGY
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
- (2010) Lars M. Ittner et al. NATURE REVIEWS NEUROSCIENCE
- Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
- (2010) Sang-Won Min et al. NEURON
- Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy
- (2010) E Morselli et al. Cell Death & Disease
- Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation
- (2009) Hyunkyung Jeong et al. CELL
- Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity
- (2009) Dirk Beher et al. Chemical Biology & Drug Design
- Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington’s disease
- (2008) Judit Pallos et al. HUMAN MOLECULAR GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started